|

COVID-19 Fears May Lead to Delayed Mesothelioma Diagnosis

ByAlex Strauss

delayed mesothelioma diagnosisCancer experts are warning that the fear of contracting COVID-19 may result in delayed mesothelioma diagnosis and worse outcomes for some patients. 

A study from the Epic Health Research Network shows that many patients delayed cancer screenings and other preventative health appointments during the pandemic. 

Although the numbers have started to increase, the trend may mean that some patients have already faced a delayed mesothelioma diagnosis. 

Understanding Pleural Mesothelioma

Pleural mesothelioma is a fast-growing cancer on the tissue that surrounds the lungs and lines the chest wall. It is most common in people who lived or worked around asbestos. 

Even in the best of times, mesothelioma is extremely difficult to diagnose. Most mesothelioma patients have very few symptoms until the disease is advanced. By the time most patients experience mesothelioma symptoms, it may already be too late for effective treatment. 

The prevalence of delayed mesothelioma diagnosis is one reason that mesothelioma is such a deadly cancer. Many people who contract asbestos cancer die within a year of diagnosis. 

Cancer researchers around the world are looking for ways to prevent delayed mesothelioma diagnosis and save lives. 

Avoiding Delayed Mesothelioma Diagnosis

The first set of data on cancer screening delays came out last May. It showed that colon cancer screenings dropped by 86 percent after the declaration of the COVID-19 national emergency. Screenings for breast and cervical cancer dropped by 94 percent. 

Even some people at high risk for these cancers did not show up for screenings. They were worried about contracting COVID-19. Screenings have picked up since then, but the updated Epic study shows they are still way below normal.. 

“We still haven’t caught up,” Dr. Chris Mast, vice president of clinical informatics for Epic, told the New York Times.

There is no reliable screening test for mesothelioma. Older people who worked with asbestos are at highest risk.  But research shows they may still reduce the chance of delayed mesothelioma diagnosis by seeing a doctor regularly.

If a doctor suspects mesothelioma, he or she can order tests to look further. CT scans, blood tests, and even new breath tests can help determine if the patient should have a biopsy. Biopsy is the only way to know for sure if a person has mesothelioma. 

New Screening Guidelines May Support Earlier Mesothelioma Diagnosis

New screening guidelines for smokers might help avoid some cases of delayed mesothelioma diagnosis. The guidelines recommend yearly CT screenings for people over 50 who smoked the equivalent of 20 packs a day. 

If a smoker with early mesothelioma has a CT scan, it may alert the doctor. Some small mesothelioma tumors can be surgically removed and chemotherapy may keep them from coming back. Delayed mesothelioma diagnosis reduces the chance of successful treatment. 

Sources:

“Delayed Cancer Screenings—A Second Look”, Epic Health Research Network, https://ehrn.org/articles/delayed-cancer-screenings-a-second-look

Abelson, Reed, “Advanced Cancers Are Emerging, Doctors Warn, Citing Pandemic Drop in Screenings”, March 17, 2021, New York Times online, https://www.nytimes.com/2021/03/17/health/cancer-screenings-decline-breast-colon.html

Similar Posts

Mesothelioma Blood Test May Be Possible
|

Mesothelioma Blood Test May Be Possible

ByAlex Strauss

An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma
| |

Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

ByAlex Strauss

Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

Inflammation Both “Friend and Foe” in Mesothelioma
| |

Inflammation Both “Friend and Foe” in Mesothelioma

ByAlex Strauss

An immune system response that causes mesothelioma symptoms such as fever, fatigue, and weight loss may also be helpful to clinicians as a way to find and treat the disease. Scientists with The Asbestos Diseases Research Institute in Sydney, Australia make that case that both systemic inflammation (throughout the body) and at the site of a tumor – has long been associated with mesothelioma and other cancers. Inflammation results when the body attempts to address the imbalances of cancer by producing more of certain immune system cells. Some inflammatory markers, such as CD+8 T-cells and C-reactive protein, have been linked to better prognosis in mesothelioma. Other inflammatory markers, such as certain macrophages and a high neutrophil-to-lymphocyte ratio, can signal the…

FDG PET-CT Results Could Lead to Improved Mesothelioma Treatment
| |

FDG PET-CT Results Could Lead to Improved Mesothelioma Treatment

ByAlex Strauss

In a recent study, researchers say a better understanding of certain diagnostic criteria could result in more targeted treatments for malignant mesothelioma. In a recent published report, doctors from the medical school at Dicle University in Diyarbakir, Turkey measured the relationship between PET-CT scan results and survival in 177 patients with malignant pleural mesothelioma. The patients were diagnosed between April 2007 and April 2011. They had a mean age of 55.4 and most (56%) were male. Patients in the study all had FDG PET-CT scans before beginning their mesothelioma treatment. FDG PET-CT scanning is a powerful imaging tool for mesothelioma and other cancers that combines a radioactive tracer with a combination of positron emission tomography and computed tomography scanning.  Because…

Volunteers Warned Against Mesothelioma Risk in OK
|

Volunteers Warned Against Mesothelioma Risk in OK

ByAlex Strauss

As volunteers from across the country continue to head to tornado-ravaged Oklahoma for the cleanup effort, they are being warned about a potentially serious threat to their own health. The Environmental Protection Agency (EPA) says damage to homes and buildings in Moore, Oklahoma has exposed a host of toxins including asbestos, the primary cause of malignant mesothelioma. Although asbestos has been phased out of most new construction materials, it can still be found in the insulation, caulk and joint compound, floor and ceiling tiles, and shingles of many older homes and buildings. According to the Huffington Post, many of the houses destroyed in Moore had been built in the 1960s and 1970s when asbestos use in construction was at its peak….

Mesothelioma Surgeons Report New Biopsy Technique
| |

Mesothelioma Surgeons Report New Biopsy Technique

ByAlex Strauss

A team of surgeons in Maryland have demonstrated how using a standard biopsy tool in a new way could improve the biopsy process for certain mesothelioma patients. An aggressive cancer of the pleural lining around the lungs, malignant pleural mesothelioma usually requires a tissue biopsy to make a definitive diagnosis. Often this is done using a rigid tool called a thoracoscope inserted into the chest wall while the patient is under general anesthesia. However, mesothelioma doctors at Walter Reed National Military Medical Center detail the case of a 79-year-old suspected mesothelioma patient whose biopsy was done in a minimally-invasive way, under conscious sedation, thanks to the novel use of a standard tool. Although the patient had several of the common signs…